>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
Krüppel样转录因子在肾脏中作用的研究进展
作者:荆堂堂  穆靖洲  谢岩  李妍  金萍  朱亮 
单位:大连医科大学 生理学教研室, 辽宁 大连 116044
关键词:Krüppel样转录因子 肾脏疾病 作用 综述 
分类号:R692
出版年·卷·期(页码):2020·39·第一期(79-84)
摘要:

Krüppel样转录因子(KLFs)是含有DNA结合区的锌指蛋白类转录因子,参与基因表达的调控过程,在多种相关疾病中表达异常。本文中作者对KLFs在肾脏中的作用进行综述,并讨论KLF蛋白在药物调控和治疗方面的潜在应用。

参考文献:

[1] KACZYNSKI J,COOK T,URRUTIA R.Sp1-and Kruppel-like transcription factors[J].Genome Biol,2003,4(2):1-8.
[2] PEI J,GRISHIN N V.A new family of predicted krüppel-like factor genes and pseudogenes in placental mammals[J].PLoS One,2013,8(11):e81109.
[3] CONKRIGHT M D,WANI M A,LINGREL J B.Lung Kruppel-like factor contains an autoinhibitory domain that regulates its transcriptional activation by binding WWP1,an E3 ubiquitin ligase[J].J Biol Chem,2001,276(31):29299-29306.
[4] LOMBERK G,GRZENDA A,MATHISON A,et al.Kruppel-like factor 11 regulates the expression of metabolic genes via an evolutionarily conserved protein interaction domain functionally disrupted in maturity onset diabetes of the young[J].J Biol Chem,2013,288(24):17745-17758.
[5] MCCONNELL B B,YANG V W.Mammalian Kruppel-like factors in health and diseases[J].Physiol Rev,2010,90(4):1337-1381.
[6] LOMBERK G,URRUTIA R.The family feud:turning off Sp1 by Sp1-like KLF proteins[J].Biochem J,2005,392(1):1-11.
[7] LAHIRI S K,ZHAO J.Kruppel-like factor 8 emerges as an important regulator of cancer[J].Am J Transl Res,2012,4(3):357-363.
[8] GRAHAMMER F,SCHELL C,HUBER T B.The podocyte slit diaphragm-from a thin grey line to a complex signalling hub[J].Nat Rev Nephrol,2013,9(10):587-598.
[9] LEE J W,CHOU C L,KNEPPER M A.Deep sequencing in microdissected renal tubules identififies nephron segment-specifific transcriptomes[J].J Am Soc Nephrol,2015,26 (11):2669-2677.
[10] LEUNG W K,GAO L,SIU P M,et al.Diabetic nephropathy and endothelial dysfunction:current and future therapies,and emerging of vascular imaging for preclinical renal-kinetic study[J].Life Sci,2016,166:121-130.
[11] SANGWUNG P,ZHOU G,NAYAK L,et al.KLF2 and KLF control endothelial identity and vascular integrity[J].JCI Insight,2017,2(4):e91700.
[12] LIN Z,NATESAN V,SHI H,et al.Kruppel-like factor 2 regulates endothelial barrier function[J].Arterioscler Thromb Vasc Biol,2010,30(10):1952-1959.
[13] SAUM K,CAMPOS B,CELDRAN-BONAFONTE D,et al.Uremic advanced glycation end products and protein-bound solutes induce endothelial dysfunction through suppression of Kruppel-like factor 2[J].J Am Heart Assoc,2018,7(1):e007566.
[14] ZHONG F,CHEN H,WEI C,et al.Reduced Kruppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy[J].Kidney Int,201,87(2):382-395.
[15] ZHONG F,MALLIPATTU S K,ESTRADA C,et al.Reduced Kruppel-like factor 2 aggravates glomerular endothelial cell injury and kidney disease in mice with unilateral nephrectomy[J].Am J Pathol,2016,186(8):2021.
[16] ZHONG F,LEE K,HE J C.Role of Kruppel-like factor-2 in kidney disease[J].Nephrol Ther,2018,23(4):53-56.
[17] YOSHIDA T,YAMASHITA M,IWAI M,et al.Endothelial Kruppel-like factor 4 mediates the protective effect of statins against ischemic AKI[J].J Am Soc Nephrol,2016,27 (5):1379-1388.
[18] HAYASHI K,SASAMURA H,NAKAMURA M,et al.KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria[J].J Clin Invest,2014,124(6):2523-2537.
[19] MALLIPATTU S K,HORNE S J,D'AGATI V,et al.Krüppel-like factor 6 regulates mitochondrial function in the kidney[J].J Clin Invest,2015,125(3):1347-1361.
[20] LI Y,SUI X,HU X,et al.Overexpression of KLF5 inhibits puromycininduced apoptosis of podocytes[J].Mol Med Rep,2018,18(4):3843-3849.
[21] MALLIPATTU S K,LIU R,ZHENG F,et al.Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation[J].J Biol Chem,2012,287(23):19122-19135.
[22] GUO Y,PACE J,LI Z,et al.Podocyte-specifific induction of Kruppel-like factor 15 restores differentiation markers and attenuates kidney injury in proteinuric kidney disease[J].J Am Soc Nephrol,2018,29(10):2529-2545.
[23] HAN S S,YU M Y,YOO K D,et al.Loss of KLF15 accelerates chronic podocyte injury[J].Int J Mol Med,2018,42(3):1593-1602.
[24] MENG X M,HUANG X R,XIAO J,et al.Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflflammation and fifibrosis in vivo and in vitro[J].Kidney Int,2012,81(3):266-279.
[25] XIAO X,TANG W,YUAN Q,et al.Epigenetic repression of Kruppel-like factor 4 through Dnmt1 contributes to EMT in renal fifibrosis[J].Int J Mol Med,2015,35(6):1596-1602.
[26] MREICH E,CHEN X M,ZAKY A,et al.The role of Kruppel-like factor 4 in transforming growth factor-beta-induced inflflammatory and fifibrotic responses in human proximal tubule cells[J].Clin Exp Pharmacol Physiol,2015,42(6):680-686.
[27] CHEN W C,LIN H H,TANG M J.Matrix-stiffness-regulated inverse expression of Kruppel-like factor 5 and Kruppel-like factor 4 in the pathogenesis of renal fifibrosis[J].Am J Pathol,2015,185(9):2468-2481.
[28] GU X,XU D,FU L,et al.KLF15 works as an early anti-fifibrotic transcriptional regulator in Ang Ⅱ-induced renal fifibrosis via down-regulation of CTGF expression[J].Kidney Blood Press Res,2017,42(6):999-1012.
[29] GU X,MALLIPATTU S K,GUO Y,et al.The loss of Kruppel-like factor 15 in Foxd1(+) stromal cells exacerbates kidney fifibrosis[J].Kidney Int,2017,92 (5):1178-1193.
[30] MEMON A,LEE W K.KLF10 as a tumor suppressor gene and its TGF-beta signaling[J].Cancer,2018,10(6):161.
[31] DIMARIO J X.KLF10 gene expression modulates fibrosis in dystrophic skeletal muscle[J].Am J Pathol,2018,188(5):1263-1275.
[32] SHENOY C C,KHAN Z,ZHENG Y,et al.Progressive fifibrosis:a progesterone-and KLF11-mediated sexually dimorphic female response[J].Endocri nology,2017,158(10):3605-3619.
[33] XU Y,XU S,LIU P,et al.Suberanilohydroxamic acid as a pharmacological Kruppel-like factor 2 activator that represses vascular inflflammation and atherosclerosis[J].J Am Heart Assoc,2017,6(12):e007134.
[34] XU Y,LIU P,XU S,et al.Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells[J].Sci Rep,2017,7(1):6686.
[35] HAYASHI K,SASAMURA H,NAKAMURA M,et al.Renin angiotensin blockade resets podocyte epigenome through Kruppel-like factor 4 and attenuates proteinuria[J].Kidney Int,2015,88(4):745-753.
[36] HAYASHI K,ITOH H.Transcription factors and epigenetic modulation:its therapeutic implication in chronic kidney disease[J].Arch Immunol Ther Exp,2015,63(3):193-196.
[37] GAO Y,LI H,MA X,et al.KLF6 suppresses metastasis of clear cell renal cell carcinoma via transcriptional repression of E2F1[J].Cancer Res,2017,77(2):330-342.
[38] JIE Y,HE W,YANG X,et al.Kruppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer[J].Cancer Gene Ther,2017,24(9):361-366.
[39] GAO Y,DING Y,CHEN H,et al.Targeting Kruppel-like factor 5 (KLF5) for cancer therapy[J].Curr Top Med Chem,2015,15(8):699-713.
[40] MALLIPATTU S K,GUO Y,REVELO M P,et al.Kruppel-like factor 15 mediates glucocorticoid-induced restoration of podocyte differentiation markers[J].J Am Soc Nephrol,2017,28(1):166-184.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405457 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364